Girihlet Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A
  • (Cancelled)

  • Investors
  • 6

Girihlet General Information

Description

Developer of a multi-dimensional platform designed to accelerate the discovery and monitoring of therapeutic strategies for complex immune diseases. The company's platform offers an immune map database, T and B cell sequencing assays, and tailored-based treatments, enabling healthcare professionals and patients to personalize treatments and improve the management of autoimmune diseases.

Contact Information

Website
girihlet.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2945 Webster Street
  • Oakland, CA 94609
  • United States
+1 (929)
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 2945 Webster Street
  • Oakland, CA 94609
  • United States
+1 (929)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Girihlet Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) Cancelled Generating Revenue
6. Later Stage VC 09-Mar-2022 Completed Generating Revenue
5. Seed Round 09-Aug-2018 Completed Generating Revenue
4. Seed Round 09-Aug-2016 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator 03-Jan-2016 $250K Completed Generating Revenue
1. Accelerator/Incubator 03-Sep-2015 $250K $250K Completed Generating Revenue
To view Girihlet’s complete valuation and funding history, request access »

Girihlet Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Girihlet’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Girihlet Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a multi-dimensional platform designed to accelerate the discovery and monitoring of therapeutic strategies
Discovery Tools (Healthcare)
Oakland, CA
2 As of 2024

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Girihlet Competitors (1)

One of Girihlet’s competitors is Adaptive Biotechnologies, a Formerly VC-backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adaptive Biotechnologies Formerly VC-backed Seattle, WA
You’re viewing 1 of 1 competitors. Get the full list »

Girihlet Patents

Girihlet Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2017193097-A1 Methods and compositions for determining specifc tcr and bcr chain pairings Inactive 06-May-2016
US-20190055607-A1 Methods and compositions for determining specific tcr and bcr chain pairings Inactive 06-May-2016
US-20150275200-A1 Method of isolating pure mitochondrial dna Active 05-Nov-2012 C12N15/1006

Girihlet Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Girihlet Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Digitalis Ventures Venture Capital Minority
True Ventures Venture Capital Minority
Harlem Biospace Accelerator/Incubator
IndieBio Accelerator/Incubator Minority
SOSV Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Girihlet FAQs

  • When was Girihlet founded?

    Girihlet was founded in 2012.

  • Where is Girihlet headquartered?

    Girihlet is headquartered in Oakland, CA.

  • What is the size of Girihlet?

    Girihlet has 2 total employees.

  • What industry is Girihlet in?

    Girihlet’s primary industry is Discovery Tools (Healthcare).

  • Is Girihlet a private or public company?

    Girihlet is a Private company.

  • What is Girihlet’s current revenue?

    The current revenue for Girihlet is .

  • How much funding has Girihlet raised over time?

    Girihlet has raised $3.25M.

  • Who are Girihlet’s investors?

    Digitalis Ventures, True Ventures, Harlem Biospace, IndieBio, and SOSV are 5 of 6 investors who have invested in Girihlet.

  • Who are Girihlet’s competitors?

    Adaptive Biotechnologies is a competitor of Girihlet.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process